REPLAY: October 16, 2017– 11 am PST
TITLE: “Kicking Addiction: How Naltrexone Blocks Opiod Highs in the Brain”
SPECIAL GUEST: Kenneth Corioso
http://www.inlanddetox.com & https://startingpointrecovery.com/
According to Psychology Today, Naltrexone is an opioid antagonist which has been approved by the FDA for the treatment of narcotic drug and alcohol dependence since the mid-90s. An opioid antagonist, Naltrexone is a drug which blocks the opioid receptors in the brain and prevents opioids drugs like heroin from binding to the receptors. The patient does not experience a high when using these substances.
According to Kenneth Corioso, owner and Chief Operations Officer of Inland Detox, Inc., the addiction medicine healthcare space lags behind in addressing the underlying physical and psychological roots of addiction in order to treat the whole person.
He continues, “The opioid epidemic has brought new challenges to the field of addiction medicine and there are ways to combat the increasing number of overdoses and fatalities associated with it.”
Join us as Corioso discusses the integration of cutting-edge treatments, such as Naltrexone implants, and how it gives the person suffering from substance abuse disorder a better chance of getting through the first year of sobriety.”
ABOUT KENNETH CORIOSO
Kenneth Corioso, is the Owner and Chief Operations Officer of Inland Detox, Inc. a residential, sub-acute, non-medical, drug and alcohol detox facility serving those in need of executive-level alcohol and drug detoxification. On eight acres in the Temecula Valley, the detox program is the perfect starting point towards life-long sobriety. Inland Detox is poi,sed to tackle the opioid epidemic with innovative approaches to drug and alcohol rehabilitation
